DNLI - CIK 0001714899
Denali Therapeutics Inc. has filed 763 documents with the SEC between 2017 and 2026. The most frequent type is insider trade (384 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2026-05-22 | 2026-05-21 |
| SCHEDULE 13G | - | 2026-05-15 | - |
| Quarterly report | 10-Q | 2026-05-07 | 2026-03-31 |
| Major company event | 8-K | 2026-05-07 | 2026-05-07 |
| SCHEDULE 13G/A | - | 2026-05-06 | - |
| 3/A | - | 2026-04-21 | 2026-04-10 |
| Proxy materials | DEFA14A | 2026-04-21 | - |
| Annual report to shareholders | ARS | 2026-04-21 | 2025-12-31 |
| Proxy statement | DEF 14A | 2026-04-21 | 2025-12-31 |
| New insider ownership | 3 | 2026-04-20 | 2026-04-10 |
| Major company event | 8-K | 2026-04-03 | 2026-04-03 |
| Major company event | 8-K | 2026-03-31 | 2026-03-27 |
| SCHEDULE 13G/A | - | 2026-03-26 | - |
| Major company event | 8-K | 2026-03-25 | 2026-03-25 |
| Annual report | 10-K | 2026-02-26 | 2025-12-31 |
| Major company event | 8-K | 2026-02-26 | 2026-02-26 |
| Employee stock plan | S-8 | 2026-02-26 | - |
| Insider sale notice | 144 | 2026-02-05 | - |
| Insider sale notice | 144 | 2026-02-04 | - |
| Insider sale notice | 144 | 2026-02-03 | - |
| Insider trade | 4 | 2026-01-08 | 2026-01-06 |
| Insider trade | 4 | 2026-01-08 | 2026-01-06 |
| Insider sale notice | 144 | 2026-01-06 | - |
| Insider sale notice | 144 | 2026-01-06 | - |
| Insider sale notice | 144 | 2026-01-06 | - |
| Major company event | 8-K | 2026-01-06 | 2026-01-06 |
| Insider trade | 4 | 2026-01-05 | 2026-01-03 |
| Insider trade | 4 | 2026-01-05 | 2026-01-03 |
| Insider trade | 4 | 2025-12-15 | 2025-12-11 |
| Major company event | 8-K | 2025-12-10 | 2025-12-09 |
| Prospectus supplement | 424B5 | 2025-12-10 | - |
| Prospectus supplement | 424B5 | 2025-12-09 | - |
| Insider sale notice | 144 | 2025-12-04 | - |
| Major company event | 8-K | 2025-12-04 | 2025-12-04 |
| Major company event | 8-K | 2025-12-04 | 2025-12-04 |
| Insider trade | 4 | 2025-11-06 | 2025-11-04 |
| New insider ownership | 3 | 2025-11-06 | 2025-11-04 |
| Quarterly report | 10-Q | 2025-11-06 | 2025-09-30 |
| Major company event | 8-K | 2025-11-06 | 2025-11-06 |
| SCHEDULE 13G/A | - | 2025-11-05 | - |
| Major company event | 8-K | 2025-10-14 | 2025-10-13 |
| Insider trade | 4 | 2025-09-05 | 2025-09-03 |
| Insider trade | 4 | 2025-08-14 | 2025-08-12 |
| Insider trade | 4 | 2025-08-14 | 2025-08-12 |
| Insider sale notice | 144 | 2025-08-13 | - |
| Insider sale notice | 144 | 2025-08-12 | - |
| Insider sale notice | 144 | 2025-08-12 | - |
| SCHEDULE 13G/A | - | 2025-08-12 | - |
| Quarterly report | 10-Q | 2025-08-11 | 2025-06-30 |
| Major company event | 8-K | 2025-08-11 | 2025-08-11 |